Anlon Healthcare Q1 FY26 results: revenue dips 12 percent YoY

Revenue DeclineResults View source PDF Explain this filing

AHCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.5%Reaction day

₹14.59

prior close

₹14.84

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.9%-4.4% vs market

Pharmaceuticals peers, median of 157sector+0.8%-4.3% vs sector

On the reaction day the stock moved 4.4 pts less than Nifty Microcap 250 and 4.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.3

10m

-1.8

15m

-1.4

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.5+0.9-4.4+0.8-4.3

Next day

-1.7+0.8-2.6+0.5-2.2

-2.7+0.7-3.4+0.4-3.1

+2.8+1.3+1.5+0.4+2.4

+8.0+0.5+7.5-0.1+8.2

+8.3+0.4+7.9-0.6+8.9

+6.9-1.5+8.4-1.2+8.1

15d

+2.5-2.4+4.9-1.8+4.3

-3.6-4.4+0.8-2.6-1.1

-6.8-7.2+0.5-5.4-1.4

-16.5-5.0-11.5-5.7-10.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

For Q1 FY26 ended June 30, 2025, Anlon Healthcare reported revenue from operations of Rs 3,329.72 lacs, down about 12 percent from Rs 3,783.25 lacs in Q1 FY25. Profit after tax came in at Rs 354.69 lacs versus Rs 376.35 lacs, a marginal dip. EPS stood at Rs 2.22 against Rs 0.41 earlier. Total expenses eased to Rs 2,830.48 lacs from Rs 3,236.83 lacs on lower raw material costs. The company listed on NSE and BSE on September 3, 2025, making this one of its early quarterly filings. Auditor RVD and Co issued an unqualified review report.

Likely market impact

Weak revenue print in debut post-listing quarter. Watch management commentary on demand outlook and order pipeline.